Intervention Insights announces first precision medicine platform to resolve the complexities of molecular testing for cancer care

Intervention Insights is pleased to announce the availability of Trapelo, a true advancement in the use of molecular science and targeted therapies for cancer patients. The first-of-its-kind, decision support, order management and results reporting solution for molecular testing enables real-time alignment among oncologists, labs and payors in the dynamic and increasingly complex world of precision medicine.WALTHAM, Mass., Dec. 7, 2017 /PRNewswire/ -- Intervention Insights is pleased to announce the availability of Trapelo, a true advancement in the use of molecular science and targeted therapies for cancer patients. The first-of-its-kind, decision support, order management and results...


Leave a comment

Your email address will not be published.


*